<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>56</patient-age><report-id>CA-CELGENEUS-028-21880-13013501</report-id><gender>male</gender><reactions><reaction>DECEASED</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>REVLIMID</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>10028228</indication></indications><outcomes><outcome>Death</outcome></outcomes><country>Canada</country><geo/></meta><original><ichicsr lang="en" xmlns="">
  <ichicsrmessageheader lang="en">
    <messagetype>ichicsr</messagetype>
    <messageformatversion>2.1</messageformatversion>
    <messageformatrelease>2.0</messageformatrelease>
    <messagenumb>CEL000000000001289232</messagenumb>
    <messagesenderidentifier>CELGENE</messagesenderidentifier>
    <messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
    <messagedateformat>204</messagedateformat>
    <messagedate>20130125102744</messagedate>
  </ichicsrmessageheader>
  <safetyreport lang="en">
    <safetyreportversion lang="en">0</safetyreportversion>
    <safetyreportid lang="en">CA-CELGENEUS-028-21880-13013501</safetyreportid>
    <primarysourcecountry>CA</primarysourcecountry>
    <occurcountry>CA</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>2013-01-25</transmissiondate>
    <reporttype>1</reporttype>
    <serious code="1">Yes</serious>
    <seriousnessdeath>1</seriousnessdeath>
    <seriousnessother>2</seriousnessother>
    <receivedateformat>102</receivedateformat>
    <receivedate>2013-01-22</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>2013-01-22</receiptdate>
    <additionaldocument>2</additionaldocument>
    <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
    <companynumb lang="en">CA-CELGENEUS-028-21880-13013501</companynumb>
    <medicallyconfirm>1</medicallyconfirm>
    <primarysource>
      <reporterfamilyname>Privacy</reporterfamilyname>
      <reportercountry>CA</reportercountry>
      <qualification code="3">Other Health Professional</qualification>
    </primarysource>
    <sender>
      <sendertype>1</sendertype>
      <senderorganization>CELGENEUS</senderorganization>
      <senderdepartment>Global Drug Safety</senderdepartment>
      <sendertitle>Manager</sendertitle>
      <sendergivename>Vivian</sendergivename>
      <senderfamilyname>Fonseca</senderfamilyname>
      <senderstreetaddress>300 Connell Drive, Suite 6000</senderstreetaddress>
      <sendercity>Berkeley Heights</sendercity>
      <senderstate>NJ</senderstate>
      <senderpostcode>07922</senderpostcode>
      <sendercountrycode>US</sendercountrycode>
      <sendertel>9082190331</sendertel>
      <senderfax>9086739115</senderfax>
      <senderemailaddress>vfonseca@celgene.com</senderemailaddress>
    </sender>
    <receiver>
      <receivertype>2</receivertype>
      <receiverorganization>FDAPM</receiverorganization>
      <receivergivename>Roger</receivergivename>
      <receivermiddlename>A</receivermiddlename>
      <receiverfamilyname>Goetsch</receiverfamilyname>
      <receivercountrycode>US</receivercountrycode>
    </receiver>
    <patient lang="en">
      <patientinitial>G-D</patientinitial>
      <patientbirthdateformat>102</patientbirthdateformat>
      <patientbirthdate>19560613</patientbirthdate>
      <patientsex code="1">Male</patientsex>
      <patientdeath>
        <patientdeathcause>
          <patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
          <patientdeathreport>10063378</patientdeathreport>
        </patientdeathcause>
      </patientdeath>
      <reaction>
        <primarysourcereaction lang="en">DECEASED</primarysourcereaction>
        <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
        <reactionmeddrallt>10011906</reactionmeddrallt>
        <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
        <reactionmeddrapt>10011906</reactionmeddrapt>
        <termhighlighted>3</termhighlighted>
        <reactionoutcome code="5">fatal</reactionoutcome>
      </reaction>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>REVLIMID</medicinalproduct>
        <obtaindrugcountry>CA</obtaindrugcountry>
        <drugauthorizationnumb>21-880</drugauthorizationnumb>
        <drugauthorizationcountry>US</drugauthorizationcountry>
        <drugauthorizationholder>Celgene Corporation</drugauthorizationholder>
        <drugstructuredosagenumb>10</drugstructuredosagenumb>
        <drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
        <drugdosagetext lang="en">10 Milligram</drugdosagetext>
        <drugdosageform normalized="capsule">Capsules</drugdosageform>
        <drugadministrationroute code="048">Oral</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10028228</drugindication>
        <drugstartdateformat>102</drugstartdateformat>
        <drugstartdate>2011-11-14</drugstartdate>
        <actiondrug code="6">Not Applicable</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>LENALIDOMIDE</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10011906</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Not Provided</drugresult>
        </drugreactionrelatedness>
      </drug>
      <summary lang="en">
        <narrativeincludeclinical><Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">DECEASED</Semaphore>(CANADA) <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">Initial </Semaphore>information was received on 22Jan2013 via a <Semaphore x="2009300" class="Occupation" value="Health Care Professional" score="1.00" ID="C53287">health care professional </Semaphore>at a <Semaphore x="2394141" class="Occupation" value="Pharmacist" score="1.00" ID="C51840">pharmacy </Semaphore>from the sister of a <Semaphore x="1387834" class="Patient Age" value="56" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="56" score="1.00" ID="">56 </Semaphore>year old </Semaphore>male who received <Semaphore x="1131427" class="Medicine" value="Revlimid" score="0.74" ID="256603">Revlimid </Semaphore><Semaphore x="4859317408759809" class="Medicine - Revlimid - Dose" value="10 mg" score="0.49" ID="">10 mg </Semaphore><Semaphore x="4859377538301953" class="Medicine - Revlimid - Frequency" value="PO" score="0.49" ID="">PO </Semaphore>from 14Nov2011 for the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>of <Semaphore x="3115684" class="MedDRA LLT" value="Multiple myeloma" score="1.00" ID="10028228">multiple myeloma</Semaphore>. Lot number was unknown. Relevant medical history and concomitant medications were not reported. The patient's sister reported to the <Semaphore x="2394141" class="Occupation" value="Pharmacist" score="1.00" ID="C51840">pharmacy </Semaphore>that the patient was <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">deceased</Semaphore>. The date <Semaphore x="1728496" class="Disease or Finding" value="Cause of Death" score="1.00" ID="C81239">of <Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906">death </Semaphore>and cause of <Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906">death </Semaphore></Semaphore>were <Semaphore x="2665498" class="AnatomicStructure" value="Unspecified Anatomic Sites" score="1.00" ID="C13411">not specified</Semaphore>. The reporter did not assess the causal relationship of the patient's <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">death </Semaphore>to <Semaphore x="1131427" class="Medicine" value="Revlimid" score="0.74" ID="256603">Revlimid</Semaphore>.Patient consent to <Semaphore x="2328864" class="Disease or Finding" value="Obtundation" score="1.00" ID="C28209">obtain </Semaphore>follow up information was not authorized. Follow up cannot be <Semaphore x="2328864" class="Disease or Finding" value="Obtundation" score="1.00" ID="C28209">obtained </Semaphore>for this case.</narrativeincludeclinical>
        <sendercomment lang="en">The temporal relationship between therapy and DECEASED suggests that a causal relationship is possible, but underlying disease could provide an alternative explanation.  Permission to contact the prescriber was not granted.</sendercomment>
      </summary>
    </patient>
  </safetyreport>
</ichicsr></original></faers>